摘要:目的 對慢性盆腔炎的婦科門診的治療過程和結果進行分析討論。方法 選取106例慢性盆腔炎患者隨機的分成甲組(n=53)和乙組(n=53),其中乙組患者采用西醫加護理干預的方式進行治療,甲組患者則在乙組的基礎上采用中藥外敷和灌腸的治療方法進行治療,在治療30 d后對甲乙兩組的治療效果進行比較。結果 甲組慢性盆腔炎患者治療的總有效率明顯高于乙組,差異具有統計學意義(P<0.05)。甲乙兩組慢性盆腔炎患者在治療后癥狀積分明顯下降,并且甲組患者下降的程度明顯高于乙組,差異存在統計學意義(P<0.05)。甲組患者和乙組患者用藥后的不良反發生率比較,差異存在統計學意義(P<0.05)。結論 采用中西醫結合治療的方法能提高慢性盆腔炎的治療效果,不良反應的發生率下降。
關鍵詞:慢性盆腔炎;中西醫結合;門診
Abstract:Objective To analyze and discuss the treatment process and the result of the gynecology clinic of the chronic pelvic inflammation. Methods 106 cases of chronic pelvic inflammation were randomly divided into group A (n=53) and group B (n=53), the second group was treated with western medicine plus nursing intervention for the treatment of the way, the patients in group B based on the traditional Chinese medicine treatment and enema treatment, compare the treatment effect in the treatment of 30 the days of the two groups A and B. Results The treatment group of patients with chronic pelvic inflammatory disease in the total efficiency was significantly higher than that in group B, the difference was statistically significant (P<0.05). A group of two patients with chronic pelvic inflammatory disease in the treatment of the symptom score decreased significantly, and the group of patients with loss was significantly higher than that in group B, there were statistically significant differences (P<0.05). Compare the occurrence of adverse reaction in group A and group B patients after treatment, there were statistically significant differences (P<0.05). Conclusion The combination of traditional Chinese and Western medicine treatment can improve the treatment effect of chronic pelvic inflammatory disease, the incidence of adverse reactions decreased.
Key words:Chronic pelvic inflammatory disease;Integrated traditional Chinese and Western medicine;Clinic
慢性盆腔炎主要是指女性的生殖器官以及周邊組織和盆腔腹膜出現慢性炎癥,一般情況為急性盆腔炎治療不徹底導致反復發作,形成慢性盆腔炎,主要的臨床癥狀為月經不調和白帶異常、下腹部墜脹疼痛及腰骶部酸痛和不孕癥等,大量臨床資料證明,進行中西醫的結合治療慢性盆腔炎效果明顯,可以使患者的臨床癥狀治愈或顯著改善[1]。本文選取106例慢性盆腔炎患者進行了治療研究,結果如下。
1 資料與方法
1.1一般資料 從我院近幾年的門診盆腔炎患者中抽取106例進行治療研究,隨機的分成甲組和乙組,每組各53例患者。甲組患者年齡為27~46歲,平均年齡(37.7±2.8)歲;……